Under conditions of chronic low-grade inflammation in obesity and type 2 diabetes induced by microbial dysbiosis, diaminopimelic acid activates nucleotide-binding oligomerization domain-containing protein 1 which stimulates insulin resistance and insulin trafficking in β cells [58]. The gene discussed is NOD1; the disease is type 2 diabetes mellitus.